オンコリスバイオファーマ(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4588/ - -
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2025/02/28日証協無担保0株0%0株0%50,900株-42.62%
2025/02/28日証協有担保1,289,649株+523.95%70,538株-62.16%373,000株+38.97%
2025/02/21日証協無担保0株0%0株0%88,700株-11.92%
2025/02/21日証協有担保206,691株-85.55%186,399株+122.68%268,407株-52.59%
2025/02/14日証協無担保0株0%0株0%100,700株+413.78%
2025/02/14日証協有担保1,430,528株+69%83,708株-46.94%566,112株+122.88%
2025/02/07日証協無担保0株0%0株0%19,600株-65.91%
2025/02/07日証協有担保846,470株-40.13%157,754株+11.56%254,000株+85.27%
2025/01/31日証協無担保0株0%0株0%57,500株-31.55%
2025/01/31日証協有担保1,413,834株-20.4%141,404株-49.05%137,100株-84.36%
2025/01/24日証協無担保0株0%0株0%84,000株+48.41%
2025/01/24日証協有担保1,776,164株-13.28%277,525株-4.78%876,700株+133.91%
2025/01/17日証協無担保0株0%0株0%56,600株+15.04%
2025/01/17日証協有担保2,048,136株+41.21%291,463株-19.84%374,800株+83.89%
2025/01/10日証協無担保0株0%0株0%49,200株-57.52%
2025/01/10日証協有担保1,450,434株+9999.99%363,590株+2784.72%203,812株+1019.78%
2024/12/30日証協無担保0株0%0株0%115,810株-74.63%
2024/12/30日証協有担保4,100株-99.85%12,604株-96.8%18,201株-95.3%
2024/12/27日証協無担保0株0%0株0%456,401株+486.61%
2024/12/27日証協有担保2,659,020株+252.63%394,292株+26.68%387,006株-4.63%
2024/12/20日証協無担保0株0%0株0%77,803株-30.41%
2024/12/20日証協有担保754,064株-69.52%311,255株+219.1%405,785株+29.07%
2024/12/13日証協無担保0株0%0株0%111,800株+97.12%
2024/12/13日証協有担保2,473,780株-20.16%97,540株-69.11%314,400株-70.17%
2024/12/06日証協無担保0株0%0株0%56,716株-12.61%
2024/12/06日証協有担保3,098,581株+10.04%315,721株-32.18%1,054,113株+39.68%
2024/11/29日証協無担保0株0%0株0%64,900株-47.84%
2024/11/29日証協有担保2,815,794株+218.98%465,500株+328.45%754,637株+58.34%
2024/11/22日証協無担保0株0%0株0%124,430株+19.6%
2024/11/22日証協有担保882,744株-30.39%108,648株+8%476,600株+8.56%
2024/11/15日証協無担保0株0%0株0%104,042株+263.78%
2024/11/15日証協有担保1,268,164株+195.84%100,597株+47.72%439,004株+380.3%
2024/11/08日証協無担保0株0%0株0%28,600株-42.22%
2024/11/08日証協有担保428,664株-45.14%68,099株-39.95%91,402株-29.42%
2024/11/01日証協無担保0株0%0株0%49,500株-10.16%
2024/11/01日証協有担保781,406株-47.24%113,398株-8.33%129,502株-42.85%
2024/10/25日証協無担保0株0%0株0%55,100株+30.57%
2024/10/25日証協有担保1,481,097株+34.76%123,699株+42.67%226,601株-10.19%

※株式分割は考慮していませんのでご注意ください。

Page Top